Ginkgo Bioworks (NYSE: DNA) CFO logs RSU vesting and tax sell-to-cover
Rhea-AI Filing Summary
Ginkgo Bioworks Holdings, Inc. Chief Financial Officer Steven P. Coen reported RSU vesting and related share movements. On July 16, 2026, 1,486 restricted stock units converted into Class A Common Stock. On July 17, 2026, he sold 752 shares at $7.903 per share to cover tax withholding obligations through a non-discretionary sell-to-cover arrangement.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
5 txns
Insider
Coen Steven P.
Role
See remarks
Sold
752 shs ($6K)
Approx. gross sale proceeds
$6K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock F2 | 752 | $7.903 | $6K |
| Exercise | Restricted Stock Units F1, F3 | 1,174 | -- | -- |
| Exercise | Restricted Stock Units F1, F4 | 312 | -- | -- |
| Exercise | Class A Common Stock F1 | 1,174 | -- | -- |
| Exercise | Class A Common Stock F1 | 312 | -- | -- |
Holdings After Transaction:
Restricted Stock Units — 9,014 shares (Direct);
Class A Common Stock — 51,438 shares (Direct)
Footnotes (4)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- F2. Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.
- F3. The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.
- F4. The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.
Key Figures
Shares sold: 752 shares
Sale price: $7.903 per share
RSUs converted: 1486 shares
+2 more
5 metrics
Shares sold
752 shares
Class A Common Stock sold on July 17, 2026 to cover taxes
Sale price
$7.903 per share
Price for 752-share tax sell-to-cover transaction on July 17, 2026
RSUs converted
1486 shares
Total restricted stock units converting into Class A Common Stock on July 16, 2026
RSU installments (F3)
36 monthly installments
Remaining vesting after initial 25% RSU vesting on May 1, 2024
RSU installments (F4)
46 monthly installments
Remaining vesting after initial 2/48ths RSU vesting on May 1, 2024
Key Terms
Restricted Stock Units, sell to cover, tax withholding obligations, equity incentive plans
4 terms
Restricted Stock Units financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
sell to cover financial
"equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction"
Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.
tax withholding obligations financial
"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting"
equity incentive plans financial
"The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded"
Equity incentive plans are company programs that pay employees, executives, or directors with company stock, stock options, or share units instead of or in addition to cash, aiming to align their interests with shareholders—like giving team members a stake in the house they help build. For investors this matters because such plans can motivate better company performance but also dilute existing ownership and increase reported compensation costs, so they affect future earnings, voting power, and share value.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did Ginkgo Bioworks (DNA) CFO Steven P. Coen report in July 2026?
CFO Steven P. Coen reported 1,486 RSUs converting into Class A Common Stock on July 16, 2026, and a sale of 752 shares on July 17, 2026. The sale was executed solely to satisfy tax withholding obligations tied to equity vesting.
What RSU vesting schedules apply to the Ginkgo Bioworks (DNA) awards referenced in this Form 4?
One RSU grant vests with 25% of shares on May 1, 2024, followed by 36 equal monthly installments. Another vests with 2/48ths of shares on May 1, 2024, then 46 equal monthly installments, defining the ongoing release of shares to the CFO.
Were Ginkgo Bioworks (DNA) CFO transactions reported under a Rule 10b5-1 trading plan?
The disclosure does not indicate that these trades were made under a Rule 10b5-1 trading plan. Instead, the footnotes state the sale was executed to cover tax withholding obligations in connection with equity vesting under the company’s equity incentive plans.